Literature DB >> 17904227

Enhanced cancer risk among patients with bipolar disorder.

Micha BarChana1, Itzhak Levav, Irena Lipshitz, Inna Pugachova, Robert Kohn, Abraham Weizman, Alexander Grinshpoon.   

Abstract

BACKGROUND: In contrast to numerous epidemiological studies that explored the risk for cancer among persons with schizophrenic psychoses, analogous studies conducted on people with bipolar disorder are rarer, despite some commonalities in biological, treatment-related variables and unhealthy lifestyles. This study investigates the risk for cancer among psychiatric inpatients diagnosed with bipolar disorder.
METHODS: Linkage analysis was conducted based on the psychiatric and the cancer national databases. Standardized incidence ratios (SIR) for both aggregated sites and for breast cancer were calculated by comparing the incidence rates among hospitalized patients with bipolar disorder with the incidence rates in the Jewish-Israeli general population.
RESULTS: An enhanced cancer risk was found for bipolar disorder in both genders: men, SIR 1.59 (95% CI 1.01-2.17); women, SIR 1.75 (95% CI 1.31-2.18). The risk for breast cancer was higher, but not significantly, than in the general female population, SIR 1.70 (95% CI 0.99-2.41). LIMITATIONS: Our sample was derived from psychiatric inpatients, thus it is likely that the bipolar disorder cases had greater severity. Putative factors such as diet, smoking and medications were not investigated.
CONCLUSIONS: Our study showed an enhanced risk for cancer among patients with bipolar disorder. Clinicians might note this risk for timely diagnosis and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17904227     DOI: 10.1016/j.jad.2007.09.003

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  17 in total

1.  Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder.

Authors:  Deniz Ceylan; Gamze Tuna; Güldal Kirkali; Zeliha Tunca; Güneş Can; Hidayet Ece Arat; Melis Kant; Miral Dizdaroglu; Ayşegül Özerdem
Journal:  DNA Repair (Amst)       Date:  2018-03-30

2.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

3.  Is lithium potentially a trace element?

Authors:  Takeshi Terao
Journal:  World J Psychiatry       Date:  2015-03-22

4.  A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research.

Authors:  Tony P George; Becky S Wu; Andrea H Weinberger
Journal:  J Dual Diagn       Date:  2012-05-11

5.  Breast cancer treatment of women with schizophrenia and bipolar disorder from Philadelphia, PA: lessons learned and suggestions for improvement.

Authors:  Marion Cole; Aruna Padmanabhan
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

6.  Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

Authors:  Gen-Min Lin; Yu-Jung Chen; De-Jhen Kuo; Lamin E S Jaiteh; Yi-Chung Wu; Tzu-Shun Lo; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2011-11-01       Impact factor: 9.306

7.  Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions.

Authors:  Chad D Morris; Jeanette A Waxmonsky; Mandy G May; David G Tinkelman; Miriam Dickinson; Alexis A Giese
Journal:  Community Ment Health J       Date:  2011-05-10

8.  Matrix metalloproteinase-9 gene and bipolar mood disorder.

Authors:  Janusz K Rybakowski; Maria Skibinska; Anna Leszczynska-Rodziewicz; Leszek Kaczmarek; Joanna Hauser
Journal:  Neuromolecular Med       Date:  2009-06-18       Impact factor: 3.843

9.  Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer.

Authors:  Ng Chong Guan; Fabian Termorshuizen; Wijnand Laan; Hugo M Smeets; Nor Zuraida Zainal; René S Kahn; Niek J De Wit; Marco P M Boks
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-27       Impact factor: 4.328

10.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.